Please login to the form below

Not currently logged in


This page shows the latest dapagliflozin news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca’s heart failure drug Farxiga scores FDA priority review

AstraZeneca’s heart failure drug Farxiga scores FDA priority review

AZ had submitted a supplemental new drug application (sNDA) for Farxiga (dapagliflozin), as a treatment to reduce the risk of cardiovascular death or the worsening of heart failure in adults with

Latest news

More from news
Approximately 8 fully matching, plus 84 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Happy Chinese New Year 2020 - The Year of The Rat
A fond farewell to The Year of the Pig...
White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...